Parker Albert P 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Jan 25, 2023
Insider Transaction Report
Form 4
Parker Albert P
Chief Legal Officer
Transactions
- Award
Common Stock
2023-01-24+170,000→ 205,000 total
Footnotes (1)
- [F1]The restricted stock award will fully vest in two installments, subject to continued employment with the Company through the applicable vesting date: 1/3 of the restricted stock will vest on February 1, 2024; and 2/3 of the restricted stock will vest on February 1, 2025.